The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
about
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesTowards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor VaccinesThe Role of FcRn in Antigen PresentationThe known unknowns of the human dendritic cell networkTrial watch: Dendritic cell-based anticancer therapyHuman monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17ACross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsHarnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.Dendritic cells during Staphylococcus aureus infection: subsets and roles.A unique dermal dendritic cell subset that skews the immune response toward Th2Enterovirus-infected β-cells induce distinct response patterns in BDCA1+ and BDCA3+ human dendritic cells.Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets.Quantitative expression of C-type lectin receptors in humans and miceA new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.Trial watch: Dendritic cell-based interventions for cancer therapyAntigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentationCMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.Dendritic cell targeted vaccines: Recent progresses and challenges.The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.Dendritic cell immunotherapy in ovarian cancer.Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy.Dendritic cells: cellular mediators for immunological toleranceThe role of lung dendritic cell subsets in immunity to respiratory viruses.Understanding the biology of antigen cross-presentation for the design of vaccines against cancer.Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines.Design of nanomaterial based systems for novel vaccine development.Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.Dendritic cells as therapeutic targets in neuroinflammation.The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets.Identification of AREG and PLK1 pathway modulation as a potential key of the response of intracranial 9L tumor to microbeam radiation therapy.Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel.In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4(+) T cell responses protecting from airway challenge with recombinant vaccinia-gag virus.CD1- and CD1+ porcine blood dendritic cells are enriched for the orthologues of the two major mammalian conventional subsets.A subset of human plasmacytoid dendritic cells expresses CD8α upon exposure to herpes simplex virus type 1.Nomenclature of CD molecules from the Tenth Human Leucocyte Differentiation Antigen Workshop.
P2860
Q26752558-A36DF826-B1BB-4FF7-BD3D-7FEF0548BBF2Q26773073-C4587246-EEF2-4604-A105-0888B3826973Q26852988-B8CE896A-B95A-4CEF-B191-D8CAB4670761Q26865854-DCB41CAF-32AB-49D6-89D7-9B32F60D3E2FQ27024047-8328DE3B-26A1-4AAA-9E31-E6C8B93A79ABQ28394790-9C312F0D-E7EA-4822-929B-A93620D39F91Q33613138-3B775623-EE9C-427F-B3CA-A76196A36AC1Q33659782-0E593038-C326-406B-B939-7126B2240FEBQ34788587-40D01953-0741-468C-97D9-C97070575B46Q34988945-9E58F5F3-61C9-4909-BAFF-7C3C379B5ABEQ35586004-93773E69-D525-491B-9169-116E5671A8B6Q35919896-379841E5-6FE8-4EEF-9AA8-A54FB6880E69Q36202435-D4B7B904-938E-4317-AB9D-41F67A445AA6Q36256534-808F9B89-A095-421E-8C8A-D37FE038D341Q36388529-5424F402-5DCE-4E8A-8FC6-8EE42A57201CQ36822696-C20205B9-01BE-403A-9C0E-CD179C1E9DD4Q37078990-27D034C8-0ECF-419C-8A92-2D33A3E2C6B4Q37135259-7835A95E-BDD4-444B-8ADC-DB7BF810CB19Q37727859-E69FFD3C-A567-4895-92E3-588771903118Q38025997-ED196C47-8993-40E4-BFED-0714B9629D60Q38069183-C7BC66F4-F02F-4BE5-ADCA-06C92401B18AQ38110935-47060B9B-4969-478C-A0E0-32FC3972A5A5Q38114071-92A9A111-B4CC-4314-A309-B332C35662B8Q38129081-BB906B20-F278-4996-9278-0D3E7DD8AEBCQ38208305-042B3098-7CA3-4B84-BD98-127A905AA7B7Q38209325-5BCF2BAC-8570-481E-9EDD-A1C99D256CD1Q38620773-904E8C10-09BB-4AF1-82A8-C654A87D538EQ38739675-EFF960AB-65FF-4F28-942D-5C3A97F5F33CQ38756454-AF37623C-AAAB-446D-A949-D778954A8CA2Q38771884-C095F2FD-618A-4A39-8FAD-BC4F742949CDQ38800252-3534502A-D0D8-4B73-B429-B80940EE0BEFQ38821711-8C13CCD5-8A5A-45F7-B536-9FC0B15715DAQ38941630-DC779762-E418-4125-8CD3-F594FBBF8BA0Q39232046-887A3ACF-E408-4F5D-9EB3-17E1731894EAQ39448429-7127A694-57CE-4D45-8292-47922BEB3A21Q39979829-E785A89F-52DB-4C09-A45D-B23892DF5803Q40214060-468AAEE4-1BE6-4D1A-9ABD-0D198E5AC46FQ40371989-62FB8F39-8D16-4783-AC38-BF100A3DF96BQ41155777-B9A84576-68B3-4826-9AB2-8EE7E96FDA73Q41882122-CED75A8C-6D5F-4EEA-8CBE-9B41CAD716CE
P2860
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
description
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 10 January 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2012
@uk
name
The C-type lectin receptor CLE ...... BDCA3+ myeloid dendritic cells
@en
The C-type lectin receptor CLEC9A mediates antigen uptake and
@nl
type
label
The C-type lectin receptor CLE ...... BDCA3+ myeloid dendritic cells
@en
The C-type lectin receptor CLEC9A mediates antigen uptake and
@nl
prefLabel
The C-type lectin receptor CLE ...... BDCA3+ myeloid dendritic cells
@en
The C-type lectin receptor CLEC9A mediates antigen uptake and
@nl
P2093
P50
P1433
P1476
The C-type lectin receptor CLE ...... BDCA3+ myeloid dendritic cells
@en
P2093
Gordon D Brown
Gosse J Adema
Lieke J J Klinkenberg
Luis J Cruz
Martin Kreutz
Paul J Tacken
P304
P356
10.1182/BLOOD-2011-08-373944
P407
P577
2012-01-10T00:00:00Z